Submission of Annual Report for the financial year ended 31st March, 2025.

Novelix Pharmaceuticals has submitted its 31st Annual Report for the financial year ended 31st March 2025 to BSE, along with the notice for its 31st Annual General Meeting scheduled for Friday, 19th September 2025 at 3:00 PM via video conferencing. The AGM notice includes ordinary business such as adoption of audited financial statements and re-appointment of director Mr. Jivamohan Divakar Valluri. Several special business items are also on the agenda, most notably proposals to raise the company's borrowing limit under Section 180(1)(c) to Rs. 500 Crores, approve creation of mortgage/charge on assets, and permit investments, loans and guarantees up to Rs. 500 Crores under Sections 186 and 185. The notice also seeks shareholder approval to appoint Ms. Mayuri Baidya as Independent Director for 5 years and Mr. Gattu Gnana Prakash as Non-Executive Non-Independent Director, and to appoint M/s. Khushbu Kanwar & Co. as Secretarial Auditors for a 5-year term (FY 2025-30). E-voting facility will be provided by CDSL with the cut-off date set as 12th September 2025.